These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 12861058)
21. Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer. Swisher EM; Wollan M; Mahtani SM; Willner JB; Garcia R; Goff BA; King MC Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):662-7. PubMed ID: 16150257 [TBL] [Abstract][Full Text] [Related]
23. Unifocal origin of advanced human epithelial ovarian cancers. Mok CH; Tsao SW; Knapp RC; Fishbaugh PM; Lau CC Cancer Res; 1992 Sep; 52(18):5119-22. PubMed ID: 1516069 [TBL] [Abstract][Full Text] [Related]
24. K-ras mutations in Müllerian inclusion cysts associated with serous borderline tumors of the ovary. Alvarez AA; Moore WF; Robboy SJ; Bentley RC; Gumbs C; Futreal PA; Berchuck A Gynecol Oncol; 2001 Feb; 80(2):201-6. PubMed ID: 11161860 [TBL] [Abstract][Full Text] [Related]
25. p53 Mutations and microsatellite instability in ovarian cancer: Yin and yang. Buller RE; Shahin MS; Holmes RW; Hatterman M; Kirby PA; Sood AK Am J Obstet Gynecol; 2001 Apr; 184(5):891-902; discussion 902-3. PubMed ID: 11303196 [TBL] [Abstract][Full Text] [Related]
26. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis. Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057 [TBL] [Abstract][Full Text] [Related]
27. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Chen X; Bonnefoi H; Diebold-Berger S; Lyautey J; Lederrey C; Faltin-Traub E; Stroun M; Anker P Clin Cancer Res; 1999 Sep; 5(9):2297-303. PubMed ID: 10499596 [TBL] [Abstract][Full Text] [Related]
28. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform. Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969 [TBL] [Abstract][Full Text] [Related]
29. Genetic analysis of benign ovarian tumors. Thomas NA; Neville PJ; Baxter SW; Campbell IG Int J Cancer; 2003 Jul; 105(4):499-505. PubMed ID: 12712441 [TBL] [Abstract][Full Text] [Related]
30. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945 [TBL] [Abstract][Full Text] [Related]
31. Multiple detection of genetic alterations in tumors and stool. Rengucci C; Maiolo P; Saragoni L; Zoli W; Amadori D; Calistri D Clin Cancer Res; 2001 Mar; 7(3):590-3. PubMed ID: 11297253 [TBL] [Abstract][Full Text] [Related]
32. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms. Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578 [TBL] [Abstract][Full Text] [Related]
33. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms. Tibiletti MG; Bernasconi B; Furlan D; Bressan P; Cerutti R; Facco C; Franchi M; Riva C; Cinquetti R; Capella C; Taramelli R Clin Cancer Res; 2001 Nov; 7(11):3404-9. PubMed ID: 11705855 [TBL] [Abstract][Full Text] [Related]
34. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene. Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504 [TBL] [Abstract][Full Text] [Related]
35. Microdissection-based mutational genotyping of serous borderline tumors of the ovary. Krishnamurti U; Sasatomi E; Swalsky PA; Jones MW; Finkelstein SD Int J Gynecol Pathol; 2005 Jan; 24(1):56-61. PubMed ID: 15626917 [TBL] [Abstract][Full Text] [Related]
36. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis. Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523 [TBL] [Abstract][Full Text] [Related]
37. Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway. Yamamoto S; Tsuda H; Takano M; Hase K; Tamai S; Matsubara O J Pathol; 2008 Sep; 216(1):103-10. PubMed ID: 18600856 [TBL] [Abstract][Full Text] [Related]
38. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma. Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277 [TBL] [Abstract][Full Text] [Related]
39. Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer. Liu MC; Choong DY; Hooi CS; Williams LH; Campbell IG Cancer Lett; 2007 Mar; 247(1):91-7. PubMed ID: 16644110 [TBL] [Abstract][Full Text] [Related]
40. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas. Schoedel KE; Finkelstein SD; Ohori NP Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]